申请人:GLAXO GROUP LTD
公开号:WO2011151361A1
公开(公告)日:2011-12-08
The invention relates to tricyclic derivatives, and their use in treating diseases and conditions mediated by antagonism of the mGluR5 receptor, in particular substance related disorders. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
该发明涉及三环衍生物,以及它们在治疗通过mGluR5受体拮抗作用介导的疾病和状况中的应用,尤其是与物质相关的障碍。此外,该发明还涉及包含这些衍生物的组合物及其制备过程。